BIOLASE and Sirona Dental Systems are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. BIOLASE currently has a consensus target price of $2.50, suggesting a potential upside of 382.63%.
No comments:
Post a Comment